Unknown

Dataset Information

Lack of Ovarian Secretions Reverts the Anabolic Action of Olanzapine in Female Rats.


ABSTRACT:

Background

Olanzapine is an orexigenic antipsychotic drug associated with serious metabolic adverse effects in humans. Development of valid rodent models for antipsychotic-induced metabolic adverse effects is hampered by the fact that such effects occur in females only. Estradiol is a predominant female hormone that regulates energy balance. We hypothesized that the female-specific hyperphagia and weight gain induced by olanzapine in the rat are dependent on the presence of estrogens.

Methods

Female sham-operated or ovariectomized rats were treated with a single injection of olanzapine depot formulation. Food intake, body weight, plasma lipids, lipogenic gene expression, energy expenditure, and thermogenic markers including brown adipose tissue uncoupling protein 1 protein l

SUBMITTER: Skrede S 

PROVIDER: S-EPMC5716078 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature